March 3, 2022 Sophia Vida
Biotech & Pharma

Biogen Gets Analyst Upgrade and Announces Layoffs

Shares of biotech company Biogen were moving higher on Thursday after the company received an upgrade from an analyst. RBC Capital Markets analyst Brian Abrahams upgraded Biogen stock on hopes for its Alzheimer’s drugs. Abrahams sees an $8 billion peak opportunity if the CMS decision comes out in Aduhelm’s favor and if Biogen succeeds with … Continue reading “Biogen Gets Analyst Upgrade and Announces Layoffs”